Banka BioLoo Limited has informed the Exchange about Investor Presentation
BANKA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Banka BioLoo Limited submitted its Q3 FY25-26 investor presentation to NSE. Standalone revenue grew 15% YoY to ₹1,878 lakhs (Gross Sales), with total income up 12% to ₹1,597 lakhs. EBITDA swung from a loss of ₹33.6 lakhs to a profit of ₹90 lakhs (~373% improvement), driven by cost optimisation and higher WaSH execution. Net loss narrowed sharply from ₹146 lakhs to ₹22 lakhs. On a consolidated basis, total income rose 8% to ₹1,531 lakhs, EBITDA jumped to ₹156 lakhs from ₹15 lakhs, and PAT loss shrank to ₹12 lakhs. The 9-month order book stands at ₹66.7 crore, with total unexecuted orders at ₹113 crore, including ₹14.64 crore of new WaSH orders won in Q3. No new railway orders were received in the quarter.
The sharp swing to profitability on both standalone and consolidated bases, combined with a healthy ₹113 crore unexecuted order book, signals improving operational momentum. Shareholders may view this positively, though the company remains in net loss territory and railway order inflows have stalled in the quarter.